The expression of TIM-3 on tumor cells was significantly correlated with the occurrence of symptom B (P=0.019).There was no correlation between other immune checkpoints and pathological features (P>0.05) (Tables 1, 3). This evidence concerns the gene HAVCR2 and neoplasm.